Literature DB >> 4579064

Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy.

S S Stubbs, R M Morrell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4579064

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

2.  Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Authors:  P R Lyons; P K Newman; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

3.  Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats.

Authors:  Imam H Shaik; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2012-07-24       Impact factor: 3.534

Review 4.  Immediate and Delayed Hypersensitivity Reactions to Corticosteroids: Evaluation and Management.

Authors:  Iris M Otani; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

5.  Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy.

Authors:  G Nasswetter; D J Piñeiro; O M Garcia Morteo; J A Maldonado Cocco; J C Barreira; M Vazquez Blanco
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

6.  Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.

Authors:  Suman Penugonda; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.

Authors:  Anjaneya P Chimalakonda; Donald L Montgomery; Jon A Weidanz; Imam H Shaik; Justin H Nguyen; John J Lemasters; Eiji Kobayashi; Reza Mehvar
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

8.  Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.

Authors:  J Kovarsky
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

9.  Atrial fibrillation following methylprednisolone pulse therapy.

Authors:  N Ueda; T Yoshikawa; M Chihara; S Kawaguchi; Y Niinomi; T Yasaki
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

10.  Intravenously given methylprednisolone in refractory asthma.

Authors:  H A Krouse; S M Santiago; W B Klaustermeyer
Journal:  West J Med       Date:  1980-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.